OAT3/SLC22A8 Substrates
DBCAT002661Pharmacologic class
A DrugBank category of 96 drugs. 82 of them are approved.
- Also known as
- OAT3 Substrates · OAT3-Substrates · OAT3/SCL22A8 Substrates · SLC22A8 Substrates
- Drugs
- 2,3-Dimercapto-1-propanesulfonic acid
- Abrocitinib
- Acyclovir
- Allopurinol
- Alprostadil
- Aminohippuric acid
- Avibactam
- Baricitinib
- Benzylpenicillin
- Betamethasone phosphate
- Budesonide
- Bumetanide
- Captopril
- Cefacetrile
- Cefaclor
- Cefaloridine
- Cefazolin
- Cefdinir
- Cefixime
- Cefoselis
- Cefotiam
- Ceftibuten
- Ceftizoxime
- Cephalexin
- Cholic Acid
What you can answer from here — as of August 12, 2019
Which targets do OAT3/SLC22A8 Substrates share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account